1. Glaser B, Thornton P, Otonkoski T, Junien C. Genetics of neonatal hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 2000 Mar;82(2):F79-86.
2. Prentki M, Matschinsky FM, Madiraju SRM. Metabolic signaling in fuel-induced insulin secretion. Cell Metab. 2013 Aug 6;18(2):162-85.
3. Vajravelu ME, De Leon DD. Genetic Characteristics of Patients with Congenital Hyperinsulinism. Curr Opin Pediatr. 2018 Aug;30(4):568-75.
4. Thomas P, Cote G, Wohllk N, Haddad B, Mathew P, Rabl W, Aguilar-Bryan L, Gagel R, Bryan J: Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-429.
5. Saint-Martin C, Arnoux J-B, de Lonlay P, Beiianne-Chinteiot C: KATP channel mutations in congenital hyperinsulinism. Seminars in Pediatric Surgery 2011;20:18-22.
6. Pinney SE, MacMullen C, Becker S, Lin Y-W, Hanna C, Thornton P, Ganguly A, Shyng S-L, Stanley CA: Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. The Journal of Clinical Investigation 2008;118:2877-2886
7. de Lonlay P, Fournet JC, Rahier J, Gross-Morand MS, Poggi-Travert F, Foussier V, Bonnefont JP, Brusset MC, Brunelle F, Robert JJ, Nihoul-Fekete C, Saudubray JM, Junien C: Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. The Journal of Clinical Investigation 1997;100:802-807.
8. Senniappan S, Shanti B, James C, Hussain K. Hyperinsulinaemic hypoglycaemia: genetic mechanisms, diagnosis and management. J Inherit Metab Dis 2012;35: 589-601
9. Tung JY-L, Boodhansingh K, Stanley CA, De Leon DD. Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations. Pediatr Diabetes. 2018;19(5):910-6.
10. Ferrara CT, Boodhansingh KE, Paradies E, Fiermonte G, Steinkrauss LJ, Topor LS, et al. Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2. J Clin Endocrinol Metab. 2017 01;102(3):942-9.
11. Pinney SE, Ganapathy K, Bradfield J, Stokes D, Sasson A, Mackiewicz K, et al. Dominant Form of Congenital Hyperinsulinism Maps to HK1 Region on 10q. Horm Res Paediatr [Internet]. 2013 [cited 2020 Apr 8];80(1). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3876732/
12. De Leon DD, Stanley CA. CONGENITAL HYPOGLYCEMIA DISORDERS: NEW ASPECTS OF ETIOLOGY, DIAGNOSIS, TREATMENT AND OUTCOMES. Pediatr Diabetes. 2017 Feb;18(1):3-9.
13. Cabezas OR, Flanagan SE, Stanescu H, Garda-Martinez E, Caswell R, Lango-Allen H, et al. Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphomannomutase 2. J Am Soc Nephrol JASN. 2017;28(8):2529-39.
14. Flanagan SE, Vairo F, Johnson MB, Caswell R, Laver TW, Lango Allen H, et al. A CACNA1D mutation in a patient with persistent hyperinsulinaemic hypoglycaemia, heart defects, and severe hypotonia. Pediatr Diabetes. 2017;18(4):320-3.
15. Giri D, Vignola ML, Gualtieri A, Scagliotti V, McNamara P, Peak M, et al. Novel FOXA2 mutation causes Hyperinsulinism, Hypopituitarism with Craniofacial and Endoderm-derived organ abnormalities. Hum Mol Genet. 2017 15;26(22):4315-26.
16. Меликян М.А. Врожденный гиперинсулинизм: молекулярная основа, клинические особенности и персонализированное лечение. Диссертация доктора медицинских наук. 2019 год, с 311.
17. Rahier J, Guiot Y, Sempoux C: Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Archives of Disease in Childhood - Fetal and Neonatal Edition 2000;82:F108-F112.
18. Arnoux J-B, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet J Rare Dis. 2011 Oct 3;6:63.
19. Palladino AA, Bennett MJ, Stanley CA. Hyperinsulinism in infancy and childhood: when an insulin level is not always enough. Clin Chem. 2008 Feb;54(2):256-63.
20. Choufani S, Shuman C, Weksberg R. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet. 2010 Aug 15;154C(3):343-54.
21. Subbarayan A, Hussain K. Hypoglycemia in Kabuki syndrome. Am J Med Genet A. 2014;164(2):467-71.
22. Nakamura Y, Takagi M, Yoshihashi H, Miura M, Narumi S, Hasegawa T, et al. A case with neonatal hyperinsulinemic hypoglycemia: It is a characteristic complication of Sotos syndrome. Am J Med Genet A. 2015 May;167A(5):1171-4.
23. Cappella M, Graziani V, Pragliola A, Sensi A, Hussain K, Muratori C, et al. Hyperinsulinemic Hypoglycaemia in a Turner Syndrome with Ring (X). Case Rep Pediatr [Internet]. 2015 [cited 2020 Apr 24];2015. Available from:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429216/
24. Kapoor RR, James C, Hussain K. Hyperinsulinism in developmental syndromes. Endocr Dev. 2009;14:95-113.
25. Ludwig A, Ziegenhorn K, Empting S, Meissner T, Marquard J, Holl R, et al. Glucose metabolism and neurological outcome in congenital hyperinsulinism. Semin Pediatr Surg. 2011 Feb 1;20(1):45-9.
26. Thornton PS, Stanley CA, De Leon DD, Harris D, Haymond MW, Hussain K, et al. Pediatric Endocrine Society. Recommendations from the pediatric endocrine society for evaluation and management of persistent hypoglycemia in neonates, infants, and children. J Pediatr 2015;167: 238-45
27. Stanley CA, De Leon DD, editors. Monogenic Hyperinsulinemic Hypoglycemia Disorders [Internet]. S. Karger AG; 2012. (Frontiers in Diabetes; vol. 21). Available from: http://www.karger.com/Book/Home/255677
28. Banerjee I, Salomon-Estebanez M, Shah P, Nicholson J, Cosgrove KE, Dunne MJ. Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia. Diabet Med J Br Diabet Assoc. 2019;36(1):9-21.
29 Kapoor RR, Flanagan SE, James C, Shield J, Ellard S, Hussain K Hyperinsulinaemic hypoglycaemia . Arch Dis Child . 2009 Jun;94(6):450-7.